Human Pharmaceutical Portfolio

Adsunib 12.5 mg Capsule

Product information from the Times Medicament supplied portfolio. Contact our export team to confirm current sourcing options, market requirements and commercial availability.

Molecule / StrengthSunitinib 12.5 mg
ManufacturerAdley Formulations
CategoryAnti-Cancer
This product is listed in the supplied Times Medicament unregistered product portfolio. Listing does not by itself confirm registration, licensing or availability in any specific country. Market-specific confirmation is required.